Seminari de Recerca "Aurora Borealis (BORA) increases ovarian cancer aggressiveness by enhancing the metastatic potential of malignant cells"

  Sala d’actes de la planta baixa de l'edifici Collserola del VHIR — See in map
15/03/2023 -- From 12:00h to 13:00h
Organize :
Recerca Vall d'Hebron
Modality: Presencial
Share it:

Speaker: Marta Barber Servera, predoctoral Researcher, Cancer Laboratory/Biomedical Research Group in Urology (VHIR).

Aurora Borealis (BORA) is the major activator of the mitotic kinase polo-like kinase 1 (PLK1). Both proteins are known to have an oncogenic role in the tumorigenesis and progression of ovarian cancer (OC). OC is a very aggressive tumor type usually diagnosed at advanced stages where the survival is very low and there are not targeted therapies. Our project aims to decipher the mechanisms by which BORA enhances OC aggressiveness, and also to validate BORA as a potential therapeutic target for OC. Our results indicate that BORA overexpression increases, through PLK1 activation, the expression of genes involved in epithelial-mesenchymal transition (EMT), resulting in higher migration and invasive capacities in vitro and faster metastasis formation in vivo. By contrast, BORA downregulation reduces OC cell viability in vitro and ex vivo, both as a single treatment and in combination with the standard of care (cisplatin/paclitaxel). Altogether, our results uncovered a potential new role of BORA in OC metastasis through the induction of EMT. Moreover, we demonstrated that targeting BORA with RNA-based nanotherapies reduces OC cell viability, providing a potential therapeutic opportunity for OC management.

Marta Barber Servera, predoctoral Researcher in Cell Cycle and Cancer Laboratory/Biomedical Research Group in Urology (VHIR), led by Dr. Juan Morote and Dra. Anna Santamaria (thesis supervisor). Graduated in Biomedical Science by the Universitat Autonoma de Barcelona and in the Translational Biomedical Research Master (VHIR).  

Host: Dr. Olga Méndez Fernández,  Postdoctoral researcher Biomedical Research in Urology (VHIR)

Related activities

II Jornada unidad de enfermedades autoinmunes sistémicas del servicio de medicina interna

06/20/2024 - 08:00
Unidad de Enfermedades Autoinmunes Sistémicas
More information

LGTBQIA+ Community at VHIR – Equality, diversity and inclusion in health research institutions

06/20/2024 - 12:00
More information

4º curso angioedema basado en simulación

Vall d’Hebron Centre de Simulació Clínica Avançada Pl. 5a Hospital de Traumatologia. Hospital Universitari Vall d’Hebron
06/26/2024 - 15:00
Dirigido a residentes de 3r y 4t año de Alergología
More information

Curso facilitadores en simulación virtual: plataforma SIMOONS

06/26/2024 - 16:00
Simulación Clínica
More information

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.